Alexion Pharmaceuticals Inc (NASDAQ:ALXN) (fair value) by 2%
| Website | https://alexion.com/ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Fiscal Year End | Dec 31, 2020 |
| Market Cap | $34,140,194,816 |
| Beta | 1.34239 |
| Average Volume | $2,545,568 |
| Last Dividend | 0% |
| Price on Feb 8, 2021 | $155.29 |
| Autochartist™ Valuation | $152.38 |
| Conclusion |
2% (fair value) |
| Download Report |
